"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."

Clinical trial NCT05249881 · UNKNOWN

Trial details

NCT number: NCT05249881
Sponsor: Aga Khan University
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Weight Change, Body

Start date: 2022-03-10
Primary completion: 2022-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.